Variant report
Variant | esv3357576 |
---|---|
Chromosome Location | chr9:7522764-7523301 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs565112581 | chr9:7522771-7522772 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs10114142 | chr9:7522823-7522824 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs544378113 | chr9:7522831-7522832 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs145033608 | chr9:7522861-7522862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs147552030 | chr9:7522884-7522885 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs189287788 | chr9:7522892-7522893 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs560388272 | chr9:7522902-7522903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs114496734 | chr9:7522903-7522904 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs79753244 | chr9:7522924-7522925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs370965644 | chr9:7522928-7522929 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs62532969 | chr9:7522937-7522938 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs180839841 | chr9:7522943-7522944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs549563352 | chr9:7522960-7522961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs558021558 | chr9:7522963-7522964 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs10114819 | chr9:7522987-7522988 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs535608499 | chr9:7523000-7523001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs376722045 | chr9:7523012-7523013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs36095850 | chr9:7523044-7523045 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs200209230 | chr9:7523045-7523046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs113639308 | chr9:7523083-7523084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs186584277 | chr9:7523138-7523139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs146161684 | chr9:7523141-7523142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs528947669 | chr9:7523168-7523169 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577117743 | chr9:7523186-7523187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs544605156 | chr9:7523214-7523215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs111749769 | chr9:7523217-7523218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs144356442 | chr9:7523270-7523271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs373145959 | chr9:7523275-7523276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs541951235 | chr9:7523279-7523280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs190944883 | chr9:7523283-7523284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs374558030 | chr9:7523285-7523286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Developmental delay | 21147756 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:7520000-7522800 | Weak transcription | Fetal Lung | lung |
2 | chr9:7522800-7523200 | Enhancers | Fetal Brain Male | brain |
3 | chr9:7522800-7523400 | Enhancers | Fetal Lung | lung |
4 | chr9:7523000-7523800 | Enhancers | Fetal Heart | heart |
5 | chr9:7523200-7524000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |